HDAC inhibitors and microRNAs involved in DNA methylation and deacetylation may permit epigenetic regulation of gene expression, which is directly involved in the molecular mechanism of oncogenesis and progression of endometrial cancer. Here, HDAC9 is linked to endometrial cancer.